Syndax Pharmaceuticals (SNDX) Capital Expenditures (QoQ) (2015 - 2018)

Syndax Pharmaceuticals (SNDX) Capital Expenditures (QoQ) (2015 - 2018) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Syndax Pharmaceuticals 1.87 Bn 1.52 Bn 53.02 Mn

Historic Data

Download Data
DateValue
Mar 31, 2018 311.90%
Dec 31, 2017 4,100.00%
Sep 30, 2016 -58.65%
Jun 30, 2016 82.19%
Mar 31, 2016 135.48%
Dec 31, 2015 138.46%